Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells
about
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonismClusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cellsDeregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancerTargeting the ubiquitin pathway for cancer treatmentDysregulation of ubiquitin ligases in cancerNF-κB, JNK, and TLR Signaling Pathways in HepatocarcinogenesisREDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligaseA genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine.Circadian gene variants in cancer.Roles of F-box proteins in cancerE3 ubiquitin ligases as cancer targets and biomarkers.SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protectionThe Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.SCF E3 ubiquitin ligases as anticancer targets.The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.Prospects of RNA interference therapy for cancer.Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signalsCopy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer.NF-kappaB signaling pathway and its therapeutic implications in human diseases.SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migrationAblation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB.The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.Targeting NF-kappaB for colorectal cancer.Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.MicroRNA regulation of F-box proteins and its role in cancer.MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting β-TrCP2.Recent advances in SCF ubiquitin ligase complex: Clinical implicationsInhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.Regulation of cancer stem cells by RING finger ubiquitin ligases.DEPTOR has growth suppression activity against pancreatic cancer cells.Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stressProlonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett's epithelium.Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection.Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
P2860
Q21090517-3A8A17EF-737E-4CD7-B7FA-0001470B8021Q24294824-DA9ECC17-DBAF-4189-B9E8-DC952CCAA4C6Q24648025-FA209E95-8C9C-4DA0-BB99-E447503214FBQ26866185-6E6668E7-37C6-4FD3-9262-322452521D56Q28086796-02F3D225-BE7C-46F0-AC31-CE7A6AB899D5Q28384956-4C1A9848-27C2-4A23-B6DC-C39572C7C8CDQ28390295-0421D17F-24F2-4F3A-A430-ACEA9C91B5B3Q28943270-9AF1ECF4-C1A2-47DD-AA88-BCFAD74EFE49Q30278581-FDA58F04-6783-4D08-A4B2-92BB87E687A9Q33714709-BF67959C-50C6-4BA8-A249-215378EEF34BQ34127839-BBE0E6CE-E3D6-4542-8EC1-3338132892C5Q35012352-F017964D-458A-433F-944D-918270D5A6DBQ35082710-47EB896B-1DA3-4F6B-8C7E-F98B67FAEEF3Q35613215-2552BE73-3AED-45B9-A77E-125E7FD722B9Q35726483-F06B98EB-1B9C-4864-A2D4-BBCD537B5E2BQ35880315-CC974122-4067-440C-994F-3442A1560544Q36029051-595517ED-DB83-44D6-BABB-CD7B2C6065A5Q36119281-03D240FF-775C-4692-865D-731F1F431C34Q36337922-4E46EE6B-503C-4A23-84D3-0C3B0A0066C5Q36877896-A9A05101-5A45-4F92-B64F-35DB4283286DQ36907152-629F1926-AB19-4D4D-9302-47258D250EDAQ37096504-820EAB42-FA45-4887-B109-36E430A17896Q37293337-9598A1BF-A154-497E-BE04-51E8622E5402Q37589134-26356AA2-9BBE-46B8-AF56-B9AE4CB63C1BQ37590127-71E48039-52BB-4ED9-A461-3D46DAAFDEE4Q37591349-0C11103E-5A91-4527-8A0F-6254D5D949C8Q37724387-07416BD3-430C-4514-8DAF-645FEEA4B63FQ38052131-30CA9F42-F3C0-433B-9D0E-890864CA2C5EQ38084210-4A9CC362-E0EE-4DA4-84DC-14A05810A6F8Q38087182-71CE556B-02DB-4605-9BFE-E5A2E13A78EFQ38577492-A29AD06F-7433-49B1-A936-B8CFF3C52FD2Q38734954-55D5360D-38A4-4DC9-80E3-D8122D2755F8Q38828721-137FE7AF-DD6B-41A5-B53E-A999E63FA0E1Q38835111-F730D994-6AAF-470B-B8C8-5668C289D23AQ38881445-97D643EF-BAAD-4E32-AC26-6FB7129C58D7Q38924935-248E3D83-4364-4F12-8F9B-3CA4393ED616Q39047635-458272AD-799C-4BAA-855D-6C2FDD57F3D9Q39235953-B2C1F9D3-A3CA-4CA3-8AB0-D1DA4617359AQ39242497-E440D38A-FB64-4BDD-836C-4B75F2009C69Q39251887-01E09171-B0D1-4BD3-AB10-EBF341E8E461
P2860
Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Increased expression of the E3 ...... in pancreatic carcinoma cells
@ast
Increased expression of the E3 ...... in pancreatic carcinoma cells
@en
Increased expression of the E3 ...... in pancreatic carcinoma cells
@nl
type
label
Increased expression of the E3 ...... in pancreatic carcinoma cells
@ast
Increased expression of the E3 ...... in pancreatic carcinoma cells
@en
Increased expression of the E3 ...... in pancreatic carcinoma cells
@nl
prefLabel
Increased expression of the E3 ...... in pancreatic carcinoma cells
@ast
Increased expression of the E3 ...... in pancreatic carcinoma cells
@en
Increased expression of the E3 ...... in pancreatic carcinoma cells
@nl
P2093
P50
P3181
P1433
P1476
Increased expression of the E3 ...... in pancreatic carcinoma cells
@en
P2093
Alexander Arlt
Heiner Schäfer
Holger Kalthoff
Maike Grossmann
Maike Witt
Ulrich R Fölsch
P304
P3181
P356
10.1158/0008-5472.CAN-04-1626
P407
P577
2005-02-15T00:00:00Z